source
- Mount Sinai researchers map enzyme structure linked to rare metabolic disorder GA1Researchers at Icahn School of Medicine at Mount Sinai have determined the crystal structure of an upstream enzyme involved in glutaric aciduria type 1 (GA1), a rare neuro‑metabolic disease. GA1 r…
- Marrow Therapeutics raises $173M to develop bone-marrow-targeted gene therapies for blood disordersMarrow Therapeutics announced a $173 million financing round, combining a $53 million Series A led by founder Scion Life Sciences and venBio with a $120 million Series B led by OrbiMed. The compan…